Top-News
Biotechnologie USA

Fate Therapeutics Inc Aktie

Aktie
WKN:  A1W50M ISIN:  US31189P1021 US-Symbol:  FATE
1,752 €
+0,0125 €
+0,72%
03.01.25
Handeln Depot/Watchlist
Aktienanzahl *
99,24 Mio.
Marktkapitalisierung *
153,26 Mio. €
Streubesitz
-4,14%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 04.03.2024

Fate Therapeutics Inc News

27.02.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
27.02.23 - PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
25.02.23 - PR Newswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE PR ...
23.02.23 - PR Newswire
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
22.02.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
22.02.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ ...
21.02.23 - PR Newswire
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders PR Newswire
18.02.23 - PR Newswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ...
17.02.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
16.02.23 - PR Newswire
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
14.02.23 - PR Newswire
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders PR Newswire
13.02.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
13.02.23 - PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
10.02.23 - PR Newswire
FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023
FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
09.02.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
09.02.23 - PR Newswire
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
08.02.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ ...
07.02.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
06.02.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
05.02.23 - PR Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE
ROSEN, A LONGSTANDING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE ...

Newssuche

Videos

newspaper
05.01.25
Strategien mit 500-2000% Performance
Gerade als Trader mit begrenzter Kapitaldecke benötigt man Strategien, die relativ wenig Kapital binden ... Mehr »